Selected article for: "activity show and acute sars cov respiratory syndrome coronavirus"
Author: Ullrich, Sven; Nitsche, Christoph
Title: The SARS-CoV-2 main protease as drug target
  • Cord-id: f8aolprb
  • Document date: 2020_9_1
    • ID: f8aolprb
    Snippet: The unprecedented pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is threatening global health. The virus emerged in late 2019 and can cause a severe disease associated with significant mortality. Several vaccine development and drug discovery campaigns are underway. The SARS-CoV-2 main protease is considered a promising drug target, as it is dissimilar to human proteases. Sequence and structure of the main protease are closely related to those from other betacoronav
    Document: The unprecedented pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is threatening global health. The virus emerged in late 2019 and can cause a severe disease associated with significant mortality. Several vaccine development and drug discovery campaigns are underway. The SARS-CoV-2 main protease is considered a promising drug target, as it is dissimilar to human proteases. Sequence and structure of the main protease are closely related to those from other betacoronaviruses, facilitating drug discovery attempts based on previous lead compounds. Covalently binding peptidomimetics and small molecules are investigated. Various compounds show antiviral activity in infected human cells.

    Search related documents:
    Co phrase search for related documents
    • active site and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active site and low micromolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • active site and low micromolar inhibitor: 1
    • active site and low micromolar range: 1, 2, 3, 4, 5, 6
    • active site and low toxicity: 1, 2
    • active site bind and lopinavir ritonavir: 1, 2
    • active site bind and low micromolar: 1, 2, 3
    • active site bind and low micromolar range: 1, 2
    • long loop region and loop region: 1, 2, 3, 4
    • long term nature and low toxicity: 1
    • loop region and low micromolar: 1
    • loop region and low micromolar range: 1
    • lopinavir ritonavir and low micromolar: 1
    • lopinavir ritonavir and low toxicity: 1